FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.4-SNAPSHOT  |  FHIR Version n/a  User: [n/a]

387337001: Magnesium hydroxide (substance)

Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jan 2003. Module: SNOMED CT core

Descriptions:

Id Description Lang Type Status Case? Module
1461515015 Magnesium hydroxide (substance) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core
1481436010 Magnesium hydroxide en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
2672752011 Magnesium hydrate en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
1461515015 Magnesium hydroxide (substance) en Fully specified name Active Only initial character case insensitive (core metadata concept) SNOMED CT core
1461515015 Magnesium hydroxide (substance) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core
1481436010 Magnesium hydroxide en Synonym (core metadata concept) Active Only initial character case insensitive (core metadata concept) SNOMED CT core
1481436010 Magnesium hydroxide en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
2672752011 Magnesium hydrate en Synonym (core metadata concept) Active Only initial character case insensitive (core metadata concept) SNOMED CT core
2672752011 Magnesium hydrate en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
54511000195112 magnesio idrossido it Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT Switzerland NRC maintained Module
68881000195117 Magnesiumhydroxid de Synonym (core metadata concept) Active Entire term case sensitive (core metadata concept) SNOMED CT Switzerland NRC maintained Module
235551000195118 Magnesium hydroxid de Synonym (core metadata concept) Active Entire term case sensitive (core metadata concept) SNOMED CT Switzerland NRC maintained Module
822361000172117 hydroxyde de magnésium fr Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT Switzerland NRC maintained Module
822361000172117 hydroxyde de magnésium fr Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT Switzerland NRC maintained Module
54511000195112 magnesio idrossido it Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT Switzerland NRC maintained Module
68881000195117 Magnesiumhydroxid de Synonym (core metadata concept) Active Entire term case sensitive (core metadata concept) SNOMED CT Switzerland NRC maintained Module
235551000195118 Magnesium hydroxid de Synonym (core metadata concept) Active Entire term case sensitive (core metadata concept) SNOMED CT Switzerland NRC maintained Module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Magnesium hydroxide Is a Magnesium compound true Inferred relationship Existential restriction modifier (core metadata concept)
Magnesium hydroxide Is a classe d'allergènes false Inferred relationship Existential restriction modifier (core metadata concept)
Magnesium hydroxide Is a allergène médicamenteux false Inferred relationship Existential restriction modifier (core metadata concept)
Magnesium hydroxide Is a Magnesium-based antacid false Inferred relationship Existential restriction modifier (core metadata concept)
Inbound Relationships Type Active Source Characteristic Refinability Group
Magnesium hydroxide [laxative] The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Magnesium hydroxide Inferred relationship Existential restriction modifier (core metadata concept)
Magnesium hydroxide mixture BP The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Magnesium hydroxide Inferred relationship Existential restriction modifier (core metadata concept)
Product containing precisely magnesium hydroxide 83 milligram/1 milliliter conventional release oral suspension (clinical drug) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Magnesium hydroxide Inferred relationship Existential restriction modifier (core metadata concept)
Magnesium hydroxide (substance) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Magnesium hydroxide Inferred relationship Existential restriction modifier (core metadata concept) 1
Liquid paraffin+magnesium hydroxide oral emulsion BP (substance) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Magnesium hydroxide Inferred relationship Existential restriction modifier (core metadata concept)
Product containing aluminium hydroxide and magnesium hydroxide and simeticone (medicinal product) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Magnesium hydroxide Inferred relationship Existential restriction modifier (core metadata concept) 2
Aluminium hydroxide 600 mg and magnesium hydroxide 300 mg oral tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Magnesium hydroxide Inferred relationship Existential restriction modifier (core metadata concept)
Dried aluminium hydroxide gel 44 mg/mL and magnesium hydroxide 39 mg/mL oral suspension The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Magnesium hydroxide Inferred relationship Existential restriction modifier (core metadata concept)
Dried aluminium hydroxide gel 120 mg/mL and magnesium hydroxide 60 mg/mL oral suspension The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Magnesium hydroxide Inferred relationship Existential restriction modifier (core metadata concept)
Calcium carbonate + famotidine + magensium hydroxide (product) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Magnesium hydroxide Inferred relationship Existential restriction modifier (core metadata concept) 3
Product containing precisely calcium carbonate 800 milligram and famotidine 10 milligram and magnesium hydroxide 165 milligram/1 each conventional release chewable tablet (clinical drug) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Magnesium hydroxide Inferred relationship Existential restriction modifier (core metadata concept)
Product containing aluminium hydroxide and magnesium hydroxide (medicinal product) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Magnesium hydroxide Inferred relationship Existential restriction modifier (core metadata concept) 2
Product containing magnesium hydroxide and mineral oil (medicinal product) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Magnesium hydroxide Inferred relationship Existential restriction modifier (core metadata concept) 2
Product containing activated charcoal and magnesium hydroxide (medicinal product) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Magnesium hydroxide Inferred relationship Existential restriction modifier (core metadata concept) 2
Aluminium oxide- and magnesium hydroxide- and oxetacaine-containing product The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Magnesium hydroxide Inferred relationship Existential restriction modifier (core metadata concept) 2
Product containing magnesium hydroxide and omeprazole and sodium bicarbonate (medicinal product) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Magnesium hydroxide Inferred relationship Existential restriction modifier (core metadata concept) 3
Magnesium hydroxide 700 mg and omeprazole 20 mg and sodium bicarbonate 600 mg chewable tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Magnesium hydroxide Inferred relationship Existential restriction modifier (core metadata concept)
Product containing precisely magnesium hydroxide 700 milligram and omeprazole 40 milligram and sodium bicarbonate 600 milligram/1 each conventional release chewable tablet (clinical drug) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Magnesium hydroxide Inferred relationship Existential restriction modifier (core metadata concept)
Omeprazole 20mg + sodium bicarbonate 750mg + magnesium hydroxide 343 mg tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Magnesium hydroxide Inferred relationship Existential restriction modifier (core metadata concept)
Omeprazole 40mg + sodium bicarbonate 750mg + magnesium hydroxide 343 mg tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Magnesium hydroxide Inferred relationship Existential restriction modifier (core metadata concept)
Aluminium hydroxide 600 mg and magnesium hydroxide 300 mg oral tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Magnesium hydroxide Inferred relationship Existential restriction modifier (core metadata concept) 1
Aluminium hydroxide 600 mg and magnesium hydroxide 300 mg oral tablet Has basis of strength substance (attribute) False Magnesium hydroxide Inferred relationship Existential restriction modifier (core metadata concept) 1
Aluminium hydroxide 600 mg and magnesium hydroxide 300 mg oral tablet Has basis of strength substance (attribute) True Magnesium hydroxide Inferred relationship Existential restriction modifier (core metadata concept) 2
Aluminium hydroxide 600 mg and magnesium hydroxide 300 mg oral tablet Has precise active ingredient True Magnesium hydroxide Inferred relationship Existential restriction modifier (core metadata concept) 2
Product containing aluminium hydroxide and magnesium hydroxide in oral dose form (medicinal product form) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Magnesium hydroxide Inferred relationship Existential restriction modifier (core metadata concept) 2
Product containing precisely magnesium hydroxide 83 milligram/1 milliliter conventional release oral suspension (clinical drug) Has precise active ingredient True Magnesium hydroxide Inferred relationship Existential restriction modifier (core metadata concept) 1
Product containing precisely magnesium hydroxide 83 milligram/1 milliliter conventional release oral suspension (clinical drug) Has basis of strength substance (attribute) True Magnesium hydroxide Inferred relationship Existential restriction modifier (core metadata concept) 1
Dried aluminium hydroxide gel 120 mg/mL and magnesium hydroxide 60 mg/mL oral suspension Has precise active ingredient False Magnesium hydroxide Inferred relationship Existential restriction modifier (core metadata concept) 2
Dried aluminium hydroxide gel 120 mg/mL and magnesium hydroxide 60 mg/mL oral suspension Has basis of strength substance (attribute) False Magnesium hydroxide Inferred relationship Existential restriction modifier (core metadata concept) 2
Dried aluminium hydroxide gel 44 mg/mL and magnesium hydroxide 39 mg/mL oral suspension Has precise active ingredient False Magnesium hydroxide Inferred relationship Existential restriction modifier (core metadata concept) 2
Dried aluminium hydroxide gel 44 mg/mL and magnesium hydroxide 39 mg/mL oral suspension Has basis of strength substance (attribute) False Magnesium hydroxide Inferred relationship Existential restriction modifier (core metadata concept) 2
Product containing magnesium hydroxide in oral dose form (medicinal product form) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Magnesium hydroxide Inferred relationship Existential restriction modifier (core metadata concept) 1
Dried aluminium hydroxide gel- and magnesium hydroxide-containing product in oral dose form The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Magnesium hydroxide Inferred relationship Existential restriction modifier (core metadata concept) 1
Product containing dried aluminium hydroxide gel and magnesium hydroxide (medicinal product) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Magnesium hydroxide Inferred relationship Existential restriction modifier (core metadata concept) 1
Aluminium oxide and magnesium hydroxide and oxetacaine only product The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Magnesium hydroxide Inferred relationship Existential restriction modifier (core metadata concept) 2
Aluminium hydroxide and magnesium hydroxide only product The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Magnesium hydroxide Inferred relationship Existential restriction modifier (core metadata concept) 2
Product containing only aluminium hydroxide and magnesium hydroxide and simeticone (medicinal product) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Magnesium hydroxide Inferred relationship Existential restriction modifier (core metadata concept) 2
Product containing only activated charcoal and magnesium hydroxide (medicinal product) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Magnesium hydroxide Inferred relationship Existential restriction modifier (core metadata concept) 2
Calcium carbonate and famotidine and magnesium hydroxide only product The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Magnesium hydroxide Inferred relationship Existential restriction modifier (core metadata concept) 3
Product containing only dried aluminium hydroxide gel and magnesium hydroxide (medicinal product) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Magnesium hydroxide Inferred relationship Existential restriction modifier (core metadata concept) 1
Product containing only magnesium hydroxide (medicinal product) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Magnesium hydroxide Inferred relationship Existential restriction modifier (core metadata concept) 1
Product containing only magnesium hydroxide and mineral oil (medicinal product) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Magnesium hydroxide Inferred relationship Existential restriction modifier (core metadata concept) 2
Product containing only magnesium hydroxide and omeprazole and sodium bicarbonate (medicinal product) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Magnesium hydroxide Inferred relationship Existential restriction modifier (core metadata concept) 3
Aluminium hydroxide and magnesium hydroxide only product in oral dose form The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Magnesium hydroxide Inferred relationship Existential restriction modifier (core metadata concept) 2
Magnesium hydroxide only product in oral dose form The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Magnesium hydroxide Inferred relationship Existential restriction modifier (core metadata concept) 1
Dried aluminium hydroxide gel and magnesium hydroxide only product in oral dose form The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Magnesium hydroxide Inferred relationship Existential restriction modifier (core metadata concept) 1
Product containing magnesium hydroxide and omeprazole and sodium bicarbonate in oral dose form (medicinal product form) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Magnesium hydroxide Inferred relationship Existential restriction modifier (core metadata concept) 3
Product containing only magnesium hydroxide and omeprazole and sodium bicarbonate in oral dose form (medicinal product form) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Magnesium hydroxide Inferred relationship Existential restriction modifier (core metadata concept) 3
Magnesium hydroxide 700 mg and omeprazole 20 mg and sodium bicarbonate 600 mg chewable tablet Has basis of strength substance (attribute) True Magnesium hydroxide Inferred relationship Existential restriction modifier (core metadata concept) 3
Magnesium hydroxide 700 mg and omeprazole 20 mg and sodium bicarbonate 600 mg chewable tablet Has precise active ingredient True Magnesium hydroxide Inferred relationship Existential restriction modifier (core metadata concept) 3
Product containing only calcium carbonate and famotidine and magnesium hydroxide in oral dose form (medicinal product form) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Magnesium hydroxide Inferred relationship Existential restriction modifier (core metadata concept) 3
Product containing precisely calcium carbonate 800 milligram and famotidine 10 milligram and magnesium hydroxide 165 milligram/1 each conventional release chewable tablet (clinical drug) Has basis of strength substance (attribute) True Magnesium hydroxide Inferred relationship Existential restriction modifier (core metadata concept) 3
Product containing precisely calcium carbonate 800 milligram and famotidine 10 milligram and magnesium hydroxide 165 milligram/1 each conventional release chewable tablet (clinical drug) Has precise active ingredient True Magnesium hydroxide Inferred relationship Existential restriction modifier (core metadata concept) 3
Calcium carbonate- and famotidine- and magnesium hydroxide-containing product in oral dose form The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Magnesium hydroxide Inferred relationship Existential restriction modifier (core metadata concept) 3
Product containing precisely magnesium hydroxide 700 milligram and omeprazole 40 milligram and sodium bicarbonate 600 milligram/1 each conventional release chewable tablet (clinical drug) Has basis of strength substance (attribute) True Magnesium hydroxide Inferred relationship Existential restriction modifier (core metadata concept) 3
Product containing precisely magnesium hydroxide 700 milligram and omeprazole 40 milligram and sodium bicarbonate 600 milligram/1 each conventional release chewable tablet (clinical drug) Has precise active ingredient True Magnesium hydroxide Inferred relationship Existential restriction modifier (core metadata concept) 3
Product containing only aluminium hydroxide and dimeticone and magnesium hydroxide (medicinal product) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Magnesium hydroxide Inferred relationship Existential restriction modifier (core metadata concept) 2
Dried aluminium hydroxide gel 44 mg/mL and magnesium hydroxide 39 mg/mL oral suspension Has basis of strength substance (attribute) True Magnesium hydroxide Inferred relationship Existential restriction modifier (core metadata concept) 1
Dried aluminium hydroxide gel 44 mg/mL and magnesium hydroxide 39 mg/mL oral suspension Has precise active ingredient True Magnesium hydroxide Inferred relationship Existential restriction modifier (core metadata concept) 1
Dried aluminium hydroxide gel 120 mg/mL and magnesium hydroxide 60 mg/mL oral suspension Has basis of strength substance (attribute) True Magnesium hydroxide Inferred relationship Existential restriction modifier (core metadata concept) 1
Dried aluminium hydroxide gel 120 mg/mL and magnesium hydroxide 60 mg/mL oral suspension Has precise active ingredient True Magnesium hydroxide Inferred relationship Existential restriction modifier (core metadata concept) 1
Magnesium hydroxide 750 microliter/mL and mineral oil 250 microliter/mL oral emulsion Has precise active ingredient True Magnesium hydroxide Inferred relationship Existential restriction modifier (core metadata concept) 2
Magnesium hydroxide 750 microliter/mL and mineral oil 250 microliter/mL oral emulsion Has basis of strength substance (attribute) True Magnesium hydroxide Inferred relationship Existential restriction modifier (core metadata concept) 2
Magnesium hydroxide- and mineral oil-containing product in oral dose form The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Magnesium hydroxide Inferred relationship Existential restriction modifier (core metadata concept) 2
Magnesium hydroxide and mineral oil only product in oral dose form The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Magnesium hydroxide Inferred relationship Existential restriction modifier (core metadata concept) 2
Product containing precisely magnesium hydroxide 750 microliter/1 milliliter and mineral oil 250 microliter/1 milliliter conventional release oral suspension (clinical drug) Has precise active ingredient True Magnesium hydroxide Inferred relationship Existential restriction modifier (core metadata concept) 2
Product containing precisely magnesium hydroxide 750 microliter/1 milliliter and mineral oil 250 microliter/1 milliliter conventional release oral suspension (clinical drug) Has basis of strength substance (attribute) True Magnesium hydroxide Inferred relationship Existential restriction modifier (core metadata concept) 2
Product containing precisely aluminium hydroxide 58.2 milligram/1 milliliter and magnesium hydroxide 19.6 milligram/1 milliliter and oxetacaine 2 milligram/1 milliliter conventional release oral suspension (clinical drug) Has precise active ingredient True Magnesium hydroxide Inferred relationship Existential restriction modifier (core metadata concept) 3
Product containing precisely aluminium hydroxide 58.2 milligram/1 milliliter and magnesium hydroxide 19.6 milligram/1 milliliter and oxetacaine 2 milligram/1 milliliter conventional release oral suspension (clinical drug) Has basis of strength substance (attribute) True Magnesium hydroxide Inferred relationship Existential restriction modifier (core metadata concept) 3
Aluminium hydroxide- and magnesium hydroxide- and oxetacaine-containing product in oral dose form The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Magnesium hydroxide Inferred relationship Existential restriction modifier (core metadata concept) 2
Aluminium hydroxide and magnesium hydroxide and oxetacaine only product in oral dose form The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Magnesium hydroxide Inferred relationship Existential restriction modifier (core metadata concept) 2
Product containing only aluminium hydroxide and magnesium hydroxide and oxetacaine (medicinal product) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Magnesium hydroxide Inferred relationship Existential restriction modifier (core metadata concept) 3
Product containing aluminium hydroxide and magnesium hydroxide and oxetacaine (medicinal product) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Magnesium hydroxide Inferred relationship Existential restriction modifier (core metadata concept) 3
Product containing precisely aluminium hydroxide 35 milligram/1 milliliter and magnesium hydroxide 40 milligram/1 milliliter conventional release oral suspension (clinical drug) Has precise active ingredient True Magnesium hydroxide Inferred relationship Existential restriction modifier (core metadata concept) 2
Product containing precisely aluminium hydroxide 35 milligram/1 milliliter and magnesium hydroxide 40 milligram/1 milliliter conventional release oral suspension (clinical drug) Has basis of strength substance (attribute) True Magnesium hydroxide Inferred relationship Existential restriction modifier (core metadata concept) 2
Product containing precisely aluminium hydroxide 35 milligram/1 milliliter and magnesium hydroxide 40 milligram/1 milliliter and simeticone 5 milligram/1 milliliter conventional release oral suspension (clinical drug) Has precise active ingredient True Magnesium hydroxide Inferred relationship Existential restriction modifier (core metadata concept) 2
Product containing precisely aluminium hydroxide 35 milligram/1 milliliter and magnesium hydroxide 40 milligram/1 milliliter and simeticone 5 milligram/1 milliliter conventional release oral suspension (clinical drug) Has basis of strength substance (attribute) True Magnesium hydroxide Inferred relationship Existential restriction modifier (core metadata concept) 2
Product containing only aluminium hydroxide and magnesium hydroxide and simeticone in oral dose form (medicinal product form) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Magnesium hydroxide Inferred relationship Existential restriction modifier (core metadata concept) 2
Product containing aluminium hydroxide and magnesium hydroxide and simeticone in oral dose form (medicinal product form) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Magnesium hydroxide Inferred relationship Existential restriction modifier (core metadata concept) 2
Product containing aluminium hydroxide and dimeticone and magnesium hydroxide (medicinal product) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Magnesium hydroxide Inferred relationship Existential restriction modifier (core metadata concept) 2

This concept is not in any reference sets

Back to Start